Is there a role for pure clinical prediction models in prostate cancer in the contemporary era?

Giorgio Gandaglia^{1

2}, Nicola Fossati^{1

2}, Paolo Dell'Oglio^{1

2}, Francesco Montorsi^{1

2}, Alberto Briganti^{1

2}

Affiliations

¹ Division of Oncology/Unit of Urology, Urological Research Institute, L'Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale San Raffaele, Milan, Italy.
² Vita-Salute San Raffaele University, Milan, Italy.

Editorial

Giorgio Gandaglia et al. BJU Int. 2017 May.

. 2017 May;119(5):652-653.

doi: 10.1111/bju.13833.

Giorgio Gandaglia^{1

2}, Nicola Fossati^{1

2}, Paolo Dell'Oglio^{1

2}, Francesco Montorsi^{1

2}, Alberto Briganti^{1

2}

¹ Division of Oncology/Unit of Urology, Urological Research Institute, L'Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale San Raffaele, Milan, Italy.
² Vita-Salute San Raffaele University, Milan, Italy.

No abstract available

Comment on

Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
Tosoian JJ, Chappidi M, Feng Z, Humphreys EB, Han M, Pavlovich CP, Epstein JI, Partin AW, Trock BJ. Tosoian JJ, et al. BJU Int. 2017 May;119(5):676-683. doi: 10.1111/bju.13573. Epub 2016 Jul 29. BJU Int. 2017. PMID: 27367645